Abstract
Recent experiments reveal targeted therapy of tumours promotes the spread of drug-resistant cancer cells in mixed sensitive-resistant tumours. The hypothesis is that drug-stressed sensitive cells produce diffusible growth factors that stimulate the expansion of drug-resistant cells. A mathematical model employing simple ecological competition and a nonlinear motility law is able to reproduce the magnitude of observed expansion of the resistant populations volume without invoking production of diffusible growth factors. The model shows how the therapy-induced removal of the sensitive population alleviates the competitive pressure on the resistant for resources and space and confirms the in vivo experimental findings, and sheds light onto mechanisms behind the large increase of the drug-resistant cancer cells in the treated tumour.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Obenauf, A., Zou, Y., Ji, A., Vanharanta, S., Shu, W., Shi, H., Kong, X., Bosenberg, M., Wiesner, T., Rosen, N., Lo, R., Massague, J.: Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 520, 368–372 (2015)
Sun, Y., Campisi, J., Higano, C., Beer, T., Porter, P., Coleman, I., True, L., Nelson, P.: Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat. Med. 18, 1359–1368 (2012)
Wilson, T., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., Ribas, A., Li, J., Moffat, J., Sutherlin, D., Koeppen, H., Merchant, M., Neve, R., Settleman, J.: Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487, 505–509 (2012)
Korolev, K., Xavier, J., Gore, J.: Turning ecology and evolution against cancer. Nat. Rev. Cancer 14, 371–380 (2014)
Aktipis, C., Boddy, A., Gatenby, R., Brown, J., Maley, C.: Life history trade-offs in cancer evolution. Nat. Rev. Cancer 13, 883–892 (2013)
Martin, P.: Trade-offs and biological diversity: integrative answers to ecological questions. In: Martin, L., Ghalambor, C., Woods, H. (eds.) Integrative Organismal Biology, pp. 291–308. Wiley (2014)
Carré, M., Bondarenko, M., Montero, M-P., Chapuisat, G., Benabdallah, A., Le Grand, M., Braguer, D., André, N., Pasquier, E.: Metronomic scheduling: a promising strategy to manage intratumor heterogeneity and control treatment resistance. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research, April 18–22 2015, Philadelphia, PA (Cancer Res 75(15 Suppl), 2572 (2015))
Warburg, O.: On the origin of cancer cells. Science 123, 309–314 (1956)
Kallinowski, F., Vaupel, P., Runkel, S., Berg, G., Fortmeyer, H.P., Baessler, K.H., Wagner, K., Mueller-Klieser, W., Walenta, S.: Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res. 48, 7264–7272 (1988)
Peppicelli, S., Bianchini, F., Calorini, L.: Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev. 33, 823–832 (2014)
Provent, P., Benito, M., Hiba, B., Farion, R., López-Larrubia, P., Ballesteros, P., Rémy, C., Segebarth, C., Cerdán, S., Coles, J., García-Martín, M.: Serial in vivo spectroscopic nuclear magnetic resonance imaging of lactate and extracellular pH in rat gliomas shows redistribution of protons away from sites of glycolysis. Cancer Res. 67, 7638–7645 (2007)
Carmona-Fontaine, C., Bucci, V., Akkari, L., Deforet, M., Joyce, J.A., Xavier, J.B.: Emergence of spatial structure in the tumor microenvironment due to the Warburg effect. Proc. Nat. Acad. Sci. USA 110, 19402–19407 (2013)
Robertson-Tessi, M., Gillies, R.J., Gatenby, R.A., Anderson, A.R.: Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res. 75, 1567–1579 (2015)
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C.B., Joyce, J.A., Xavier, J.B.: Metabolic origins of spatial organization in the tumor microenvironment. Proc. Nat. Acad. Sci. USA 114, 2934–2939 (2017)
Hanahan, D., Weinberg, R.: Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)
Gatenby, R., Silva, A., Gillies, R., Frieden, B.: Adaptive therapy. Cancer Res. 69, 4894–4903 (2009)
Broxterman, H., Pinedo, H., Kuiper, C., Kaptein, L., Schuurhuis, G., Lankelma, J.: Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells. FASEB J. 2, 2278–2282 (1988)
Harada, D., Takigawa, N., Ochi, N., Ninomiya, T., Yasugi, M., Kubo, T., Takeda, H., Ichihara, E., Ohashi, K., Takata, S., Tanimoto, M., Kiura, K.: JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation. Cancer Sci. 103, 1795–1802 (2012)
Wang, Q., Cui, K., Espin-Garcia, O., Cheng, D., Qiu, X., Chen, Z., Moore, M., Bristow, R., Xu, W., Der, S., Liu, G.: Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis. PLoS ONE 8, e82363 (2013)
Abercrombie, M.: Contact inhibition and malignancy. Nature 281, 259–262 (1979)
Sherratt, J.: Wavefront propagation in a competition equation with a new motility term modelling contact inhibition between cell populations. Proc. R. Soc. A. 456, 2365–2386 (2000)
Sherratt, J., Chaplain, M.: A new mathematical model for avascular tumour growth. J. Math. Biol. 43, 291–312 (2001)
Bertsch, M., Hilhorst, D., Izuhara, H., Mimura, M.: A nonlinear parabolic-hyperbolic system for contact inhibition of cell-growth. Diff. Equ. Appl. 4, 137–157 (2012)
Bertsch, M., Hilhorst, D., Izuhara, H., Mimura, M., Wakasa, T.: Travelling wave solutions of a parabolic-hyperbolic system for contact inhibition of cell-growth. Eur. J. Appl. Math. 26, 297–323 (2015)
Bertsch, M., Passo, R.D., Mimura, M.: A free boundary problem arising in a simplified tumour growth model of contact inhibition. Interfaces Free Bound. 12, 235–250 (2010)
Murray, J.D.: Mathematical Biology. Springer, New York (1993)
Maezawa, H., Wong, K., Urano, M.: Radiosensitivity of mouse skin epithelial cell line established in serum-free culture: an alternative to animal use. Int. J. Radiat. Oncol. Biol. Phys. 24, 533–541 (1992)
Gatenby, R., Gawlinski, E.: A reaction-diffusion model of cancer invasion. Cancer Res. 56, 5745–5733 (1996)
Kolmogorov, A., Petrovskii, I., Piscounov, N.: A study of the diffusion equation with increase in the amount of substance, and its application to a biological problem. Bull. Moscow Univ. Math. Mech. 1, 1–25 (1937)
Benga, G.: Basic studies on gene therapy of human malignant melanoma by use of the human interferon \(\beta \)-gene entrapped in cationic multilamellar liposomes.: 1. morphology and growth rate of six melanoma cell lines used in transfection experiments with the human interferon \(\beta \)-gene. J. Cell. Mol. Med. 5, 402–408 (2001)
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E., Mueller-Klieser, W.: High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916–921 (2000)
Foo, J., Michor, F.: Evolution of acquired resistance to anti-cancer therapy. J. Theor. Biol. 355, 10–20 (2014)
Pisco, A.O., Huang, S.: Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: what does not kill me strengthens me. Br. J. Cancer 112, 1725–1732 (2015)
Weiner, R., Schmitt, B., Podhaisky, H.: ROWMAP—a ROW-code with Krylov techniques for large stiff ODEs. Appl. Numer. Math. 25, 303–319 (1997)
Hecht, F.: New development in FreeFem++. J. Numer. Math. 20, 251–265 (2012)
Acknowledgements
The author acknowledges funding for his postdoc position at the University of Exeter from AstraZeneca (Cambridge, UK). Thanks to Mark Hewlett and Bogna Pawłowska for proofreading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
Here is a brief summary of the numerical method used to solve Eqs. 7–11. The main challenge is the treatment of the non-linear flux term. For the 1D problems P1 and P2, the flux term is to rewritten as in [21]
and then the equations are integrated in time using the ROWMAP solver [34].
For the 2D problem, a variational formulation scheme is used to discretise the equations in space with Lagrangian P2 finite elements. The non-linear system is integrated in the software environment FreeFem++ [35] by a fully implicit Euler scheme, and the equations are solved iteratively at every time step by Newton’s method. For this purpose, the non-linear diffusion term is approximated as follows for a test function \(\psi \in H^1(\varOmega )\). The divergence theorem employing the homogeneous Neumann boundary conditions for \(u_j\) gives
In order to use Newton’s method for the solution of Eqs. 7–11, \(F_j\) in Eq. 16 is expanded in a Taylor series. For a small perturbation \(\tilde{u}_i\) in \(u_i\), \(F_0\), for example, is
A similar approximation is made for the other two terms \(F_1,F_2\).
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Rashkov, P. (2018). Competition for Resources and Space Contributes to the Emergence of Drug Resistance in Cancer. In: Georgiev, K., Todorov, M., Georgiev, I. (eds) Advanced Computing in Industrial Mathematics. Studies in Computational Intelligence, vol 728. Springer, Cham. https://doi.org/10.1007/978-3-319-65530-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-65530-7_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65529-1
Online ISBN: 978-3-319-65530-7
eBook Packages: EngineeringEngineering (R0)